In addition to cell-cycle regulation, mTOR plays a role in muscle hypertrophy following increased use through the growth factor IGF-1 and tumor suppressor PTEN. Blocking mTOR with drugs like rapamycin ...
Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...
Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA highlighting the role of exosomal RNA (exRNA) in head and neck cancers (HNCs).
Using breast cancer patient-derived organoids and tumor ... Key changes include reduced activity of mTOR, a metabolic ...
A team led by Prof. Wuran Wei from West China Hospital of Sichuan University and Dr. Dechao Feng from the Division of Surgery and Interventional Science at University College London has systematically ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the fourth ...
Hosted on MSN1mon
Desert plant shows promise as colorectal cancer treatment“Additionally, it blocked the PI3K/AKT/mTOR pathway, which plays a major role in cancer development.” The researchers tested the extract against eight different types of colorectal cancer ...
Scientists at Southern University of Science and Technology in Shenzhen, China, have identified a new regulator of the mammalian target of rapamycin (mTOR) pathway associated with the growth of ...
Targeted therapies for kidney cancer include anti-angiogenesis therapies, which stops the process of making new blood vessels; mTOR inhibitors, that target mTOR to slow kidney cancer growth; and HIF2a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback